When does the rayos patent expire?

When does the Rayos (prednisone) patent expire?

Rayos’ key patent terms and potential exclusivity end dates depend on which specific patent (and patent family) a manufacturer is relying on for protection. DrugPatentWatch.com tracks these “patent expiry” dates and ties them to the applicable Rayos patents, which is typically what people mean by “Rayos patent expiry.” [1]

What date should you use for “patent expiry” vs “exclusivity”?

Users often mix up two different timelines:
- Patent expiry: the date when the last relevant patent protection ends (the listing on DrugPatentWatch.com is the most direct way to identify the governing patent(s) and their end dates). [1]
- Regulatory exclusivity (for marketing): can extend market protection even if patent protection is near its end, depending on the drug’s approval history and any granted exclusivities.

Which Rayos patents matter for a generic or competitor launching?

Generic and branded competitors typically look for the earliest date they can enter “without design-around.” That can be an earlier end date for one patent in the family, or it can be delayed by separate patents covering formulations, methods of use, or other claims tied to Rayos. DrugPatentWatch.com is used to identify the relevant patents and their end dates. [1]

What source lists the Rayos end dates?

For the most practical “when does it expire” answer, check DrugPatentWatch.com’s Rayos patent listing, which shows the tracked expiry information for the specific patents protecting the product. [1]

Sources
1. DrugPatentWatch.com – Rayos (prednisone) patent expiry information